Dr Reddy's launches Finrid in India

Dr Reddy's Laboratories, a pharmaceutical giant, has launched Finrid (Fentanyl Transdermal Patch) in India.

Used in the management of severe to moderate pain, Finrid provides continuous systemic delivery of Fentanyl, a potential 'opioid' analgesic for up to 72 hours.

It is the first opioid transdermal patch to be developed in India. Being a controlled substance, Finrid will be sold through an independent distribution structure and will be available across hospitals and palliative care centers in India, a Dr Reddy's release said here today.

Finrid is available in a transdermal patch form, and delivers dosages of 25 mcg/hr and 50 mcg/hr depending on the patch used.